**Core Concept**
Beta-adrenoceptor blocking agents are a class of medications used to treat hypertension, angina, and certain arrhythmias by blocking the effects of the hormone epinephrine (adrenaline) on the heart and blood vessels. They are metabolized by the liver and excreted by the kidneys.

**Why the Correct Answer is Right**
The correct answer is **Carvedilol**. Carvedilol is a non-selective beta-blocker that is primarily metabolized by the liver but is also excreted in the urine. In patients with renal failure, the accumulation of carvedilol and its active metabolites can occur, leading to enhanced beta-blocking activity and potentially severe hypotension, bradycardia, or even cardiogenic shock. This makes carvedilol a contraindication in patients with significant renal impairment.

**Why Each Wrong Option is Incorrect**
**Option A:** **Metoprolol** is primarily metabolized by the liver and has a relatively short half-life, making it less likely to accumulate in patients with renal failure. Its active metabolite, alpha-1 acid glycoprotein, is not significantly affected by renal function.
**Option B:** **Atenolol** is primarily excreted unchanged by the kidneys, but its low lipid solubility and large volume of distribution reduce its accumulation in patients with renal failure. However, caution is still advised in patients with renal impairment.
**Option C:** **Propranolol** is primarily metabolized by the liver and has a relatively long half-life, but it is not significantly affected by renal function.

**Clinical Pearl / High-Yield Fact**
In patients with renal failure, beta-blockers should be chosen with caution, and their dosage should be adjusted according to the patient's renal function. Atenolol and metoprolol are generally safer choices than carvedilol in patients with significant renal impairment.

**Correct Answer: C. Propranolol. Propranolol**